Nutanix Inc
For the period ended Jul 31, 2024. Filed Sep 19, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Sep 19, 2024
NTNX$59.49+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| As of | ||
|---|---|---|
| July 31,2023 | July 31,2024 | |
| (in thousands, except per share data) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $512,929 | $655,270 |
| Short-term investments | 924,466 | 339,072 |
| Accounts receivable, net of allowances of $733 and $772, respectively | 157,251 | 229,796 |
| Deferred commissions—current | 120,001 | 159,849 |
| Prepaid expenses and other current assets | 147,087 | 97,307 |
| Total current assets | 1,861,734 | 1,481,294 |
| Property and equipment, net | 111,865 | 136,180 |
| Operating lease right-of-use assets | 93,554 | 109,133 |
| Deferred commissions—non-current | 237,990 | 198,962 |
| Intangible assets, net | 4,893 | 5,153 |
| Goodwill | 184,938 | 185,235 |
| Other assets—non-current | 31,941 | 27,961 |
| Total assets | $2,526,915 | $2,143,918 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $29,928 | $45,066 |
| Accrued compensation and benefits | 143,679 | 195,602 |
| Accrued expenses and other current liabilities | 109,269 | 24,967 |
| Deferred revenue—current | 823,665 | 954,543 |
| Operating lease liabilities—current | 29,567 | 24,163 |
| Total current liabilities | 1,136,108 | 1,244,341 |
| Deferred revenue—non-current | 771,367 | 918,163 |
| Operating lease liabilities—non-current | 68,940 | 90,359 |
| Convertible senior notes, net | 1,218,165 | 570,073 |
| Other liabilities—non-current | 39,754 | 49,130 |
| Total liabilities | 3,234,334 | 2,872,066 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ deficit: | ||
| Preferred stock, par value of $0.000025 per share— 200,000 shares authorized as of July 31, 2023 and 2024; no shares issued and outstanding as of July 31, 2023 and 2024 | — | — |
| Common stock, par value of $0.000025 per share—1,000,000 Class A shares authorized as of July 31, 2023 and 2024; 239,607 and 265,181 Class A shares issued and outstanding as of July 31, 2023 and 2024, respectively | 6 | 7 |
| Additional paid-in capital | 3,930,668 | 4,118,898 |
| Accumulated other comprehensive (loss) income | (5,171) | 146 |
| Accumulated deficit | (4,632,922) | (4,847,199) |
| Total stockholders’ deficit | (707,419) | (728,148) |
| Total liabilities and stockholders’ deficit | $2,526,915 | $2,143,918 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.